Ceregene
Biotechnology company that treats neurodegenerative disorders using the delivery of nervous system growth factors.
Launch date
Employees
Market cap
-
Enterprise valuation
€42—63m (Dealroom.co estimates Nov 2010.)
San Diego California (HQ)
Authorizing premium user...